148 related articles for article (PubMed ID: 30430783)
1. Cluster Containing More Than 20 CD3-Positive Cells in Bone Marrow Biopsy Is a Candidate Prognostic Indicator in Peripheral T-Cell Lymphoma, Not Otherwise Specified.
Shim H; Jang S; Huh J; Yoon DH; Suh C; Park CJ
Ann Lab Med; 2019 Mar; 39(2):200-204. PubMed ID: 30430783
[TBL] [Abstract][Full Text] [Related]
2. Subtle CD20 positivity in the bone marrow of a patient who has a mucosa-associated lymphoid tissue lymphoma should not be regarded as evidence of involvement in the bone marrow.
Won D; Park CJ; Shim H; Jang S; Chi HS; Huh J; Yoon DH; Suh C
Histopathology; 2013 Feb; 62(3):397-405. PubMed ID: 23163529
[TBL] [Abstract][Full Text] [Related]
3. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
[TBL] [Abstract][Full Text] [Related]
4. CD3 and CD20 Immunohistochemical Staining Patterns of Bone Marrow-Infiltrating Malignant Lymphoma Cells.
Lee EJ; Kim M; Kim HS; Kang HJ; Kim HJ; Min SK; Lee YK
Ann Clin Lab Sci; 2017 Mar; 47(2):136-143. PubMed ID: 28442514
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics and survival of peripheral T-cell lymphoma-not otherwise specified: a report of 57 cases].
Chen X; Dong DF; Wu YY; Huang HY; Liang J; Li EX
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):916-9. PubMed ID: 20193331
[TBL] [Abstract][Full Text] [Related]
6. Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas.
Niitsu N; Okamoto M; Nakamine H; Aoki S; Motomura S; Hirano M
Hematol Oncol; 2008 Sep; 26(3):152-8. PubMed ID: 18395866
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of bone marrow involvement at the molecular level in aggressive lymphoma.
Goldschmidt N; Darawshy F; Kleinstern G; Slyusarevsky E; Pogrebijski G; Krichevsky S; Ben-Yehuda D; Gatt ME
Leuk Lymphoma; 2017 Jan; 58(1):45-52. PubMed ID: 27756163
[TBL] [Abstract][Full Text] [Related]
8. Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified.
Zhang W; Wang L; Zhou D; Cui Q; Zhao D; Wu Y
Leuk Lymphoma; 2011 Jan; 52(1):46-52. PubMed ID: 21077742
[TBL] [Abstract][Full Text] [Related]
9. Peripheral T-cell lymphoma--not otherwise specified.
Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
[TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.
Deng XW; Zhang XM; Wang WH; Wang SL; Jin J; Fang H; Ren H; Liu YP; He XH; Dong M; Song YW; Li YX
Ann Hematol; 2016 Aug; 95(8):1271-80. PubMed ID: 27209536
[TBL] [Abstract][Full Text] [Related]
11. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma].
Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL
Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378
[TBL] [Abstract][Full Text] [Related]
13. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases.
Kato S; Takahashi E; Asano N; Tanaka T; Megahed N; Kinoshita T; Nakamura S
Histopathology; 2012 Aug; 61(2):186-99. PubMed ID: 22690710
[TBL] [Abstract][Full Text] [Related]
14. Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database.
Bhatt VR; Giri S; Verma V; Manandhar S; Pathak R; Bociek RG; Vose JM; Armitage JO
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):373-8. PubMed ID: 27349764
[TBL] [Abstract][Full Text] [Related]
15. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.
Arrowsmith ER; Macon WR; Kinney MC; Stein RS; Goodman SA; Morgan DS; Flexner JM; Cousar JB; Jagasia MH; McCurley TL; Greer JP
Leuk Lymphoma; 2003 Feb; 44(2):241-9. PubMed ID: 12688340
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified.
Shibata Y; Hara T; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Goto N; Nannya Y; Ito H; Kito Y; Miyazaki T; Takeuchi T; Saito K; Seishima M; Takami T; Moriwaki H; Shimizu M; Tsurumi H
Hematol Oncol; 2017 Dec; 35(4):637-644. PubMed ID: 27338762
[TBL] [Abstract][Full Text] [Related]
17. CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder.
Lefèvre G; Copin MC; Roumier C; Aubert H; Avenel-Audran M; Grardel N; Poulain S; Staumont-Sallé D; Seneschal J; Salles G; Ghomari K; Terriou L; Leclech C; Morati-Hafsaoui C; Morschhauser F; Lambotte O; Ackerman F; Trauet J; Geffroy S; Dumezy F; Capron M; Roche-Lestienne C; Taieb A; Hatron PY; Dubucquoi S; Hachulla E; Prin L; Labalette M; Launay D; Preudhomme C; Kahn JE;
Haematologica; 2015 Aug; 100(8):1086-95. PubMed ID: 25682606
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow histologic and immunohistochemical findings in peripheral. T-cell lymphoma: A study of 38 cases.
Gaulard P; Kanavaros P; Farcet JP; Rocha FD; Haioun C; Divine M; Reyes F; Zafrani ES
Hum Pathol; 1991 Apr; 22(4):331-8. PubMed ID: 2050367
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system involvement in T-cell lymphoma: A single center experience.
Gurion R; Mehta N; Migliacci JC; Zelenetz A; Moskowitz A; Lunning M; Moskowitz C; Hamlin P; Horwitz S
Acta Oncol; 2016 May; 55(5):561-6. PubMed ID: 27046135
[TBL] [Abstract][Full Text] [Related]
20. Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study.
Wolach O; Fraser A; Luchiansky M; Shapiro C; Radnay J; Shpilberg O; Lishner M; Lahav M
Hematol Oncol; 2015 Mar; 33(1):42-7. PubMed ID: 24470400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
